About Aprikose Pharmaceuticals Private Limited
Data last updated:
Aprikose Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24230RJ2016PTC054738. Its GSTIN is 08AAOCA3451A1ZZ (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harish Dublad and Muskan Kumawat.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at P .No. B – 2 – A Surjan Vihar Nandpuri, Jaipur, Rajasthan, India – 302006.
As per the financials filed for FY 2019, the company reported a revenue of ₹74.18 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹4.14 Lakh (net margin -5.6%) and EBITDA of -₹3.04 Lakh (EBITDA margin -4.1%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aprikosepharma.com.
Company details
Contact details
Aprikose Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its website is aprikosepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressP .No. B – 2 – A Surjan Vihar Nandpuri, Jaipur, Rajasthan, India – 302006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aprikose Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aprikose Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aprikose Pharmaceuticals Private Limited, buy the company report.
Financials of Aprikose Pharmaceuticals Private Limited
FY 2019 filings availableAprikose Pharmaceuticals Private Limited reported revenue of ₹74.18 Lakh (up 32% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 32% in the latest year. EBITDA rose 75% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹74.18 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹3.04 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹4.14 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -4.1% | ||
| Net Profit Margin | -5.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aprikose Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aprikose Pharmaceuticals Private Limited
Aprikose Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Dublad Also directs: Panashi Women Education and Environment Foundation | Director | 25 Apr 2016 | 10 Years 6 Months | Current |
| Muskan Kumawat | Additional Director | 11 May 2024 | 2 Years 6 Months | Current |
Peer comparison
Aprikose Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nispero Pharmaceuticals Private Limited | ₹74.8 Lakh (FY 2025) | 31.0% | Lucknow, Uttar Pradesh, India | |||
| Morris Pharmaceuticals Private Limited | ₹74.58 Lakh (FY 2024) | 20.0% | Varanasi, Uttar Pradesh, India | |||
| Rbco Pharmaceuticals Private Limited | ₹74.57 Lakh (FY 2024) | 88.0% | Raipur, Chhattisgarh, India | |||
| Stardevson Pharmaceuticals (OPC) Private Limited | ₹74.47 Lakh (FY 2025) | 15.0% | Bilaspur, Chhattisgarh, India | |||
| Aprikose Pharmaceuticals Private Limitedthis company | ₹74.18 Lakh (FY 2019) | -₹4.14 Lakh | -5.6% | 32.0% | Jaipur, Rajasthan, India | |
| Rholence Pharmaceuticals Private Limited | ₹73.59 Lakh (FY 2024) | 16.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Aprikose Pharmaceuticals Private Limited, buy the company report.
Auditor
Aprikose Pharmaceuticals Private Limited is audited by AGIWAL KHETAN & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGIWAL KHETAN & ASSOCIATES | FY 2019 | 024116C |
Shareholding
The shareholding of Aprikose Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aprikose Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aprikose Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aprikose Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aprikose Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAOCA3451A1ZZ | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aprikose Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aprikose Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Vikram Jeet ceased to be Director on 13 May 2024.
Frequently asked questions
Aprikose Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 April 2016 (10+ years old) and is registered under CIN U24230RJ2016PTC054738.
Aprikose Pharmaceuticals has 2 current directors:
- Harish Dublad - Director
- Muskan Kumawat - Additional Director
The latest financial statements of Aprikose Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Aprikose Pharmaceuticals is 08AAOCA3451A1ZZ, registered in Rajasthan.
The CIN (Corporate Identification Number) of Aprikose Pharmaceuticals is U24230RJ2016PTC054738. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aprikose Pharmaceuticals was incorporated on 25 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Aprikose Pharmaceuticals by revenue are Nispero Pharmaceuticals Private Limited, Morris Pharmaceuticals Private Limited, Rbco Pharmaceuticals Private Limited, Stardevson Pharmaceuticals (OPC) Private Limited, Rholence Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Vikram Jeet ceased to be Director on 13 May 2024. Muskan Kumawat was appointed as Additional Director on 11 May 2024. Harish Dublad was appointed as Director on 25 Apr 2016. Aprikose Pharmaceuticals has 4 board changes on record in total.
Aprikose Pharmaceuticals can be reached through the website aprikosepharma.com. Its registered office is in Jaipur, Rajasthan, India.
The registered office of Aprikose Pharmaceuticals is at P .No. B – 2 – A Surjan Vihar Nandpuri, Jaipur, Rajasthan, India – 302006.
Aprikose Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
